20 de octubre de 2020
7 de abril de 2008
- Comunicado -

New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe (y 2)


Web site: http://www.abbott.com
http://www.KALETRA.com
http://www.abbott.com/HIVAIDS
http://www.abbottglobalcare.org

Asia, North America and Latin America, Susan Beverly, +1-847-935-9096, or Europe and Africa, Dirk van Eeden, +1-847-224-1828, both of Abbott